×
Back to Agenda
Transparency, Expanded Access Navigator, Right to Try: Helping Patients Get Access to Investigational Medicines?
Session Chair(s)
Kim Quaintance-Lunn
Vice President, Head of Regulatory Science and Execution, Alexion, United States
Numerous steps have been taken to increase access to investigational medicines for patients with serious and life-threatening diseases. This session will explore whether these initiatives have had the desired impact.
Learning Objective : Describe changes to expanded access programs, including Right to Try; Assess the impact of these changes to the patient; Discuss ways to improve access to investigational medicines for patients.
Speaker(s)
Patient Perspective on Preapproval Access
Advocacy Coordinator, Cholangiocarcinoma Foundation, United States
Innovating Compassionate Use Request Processes with CompAC
Head, Patient Support, Janssen Pharmaceutical Companies of Johnson & Johnson, United States
Assessment of Progress
Assistant Professor, Division of Medical Ethics, Dept of Population Health, NYU Grossman School of Medicine, United States
Have an account?